David William Andrews

25PUBLICATIONS
74CO-AUTHORS
ChemotherapyMolecular targetsClinical pharmacology and therapeuticsCellular interactions (incl. adhesion, matrix, cell wall)Deep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 24, 2026
Cancer-Associated BCL-2 Mutants Reveal Mechanisms Towards Venetoclax Resistance.

|Jul 24, 2024
BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains.

Tobias B Beigl, Alexander Paul, Thomas P Fellmeth

|Jul 10, 2024
The C-terminal sequences of Bcl-2 family proteins mediate interactions that regulate cell death.

Dang Nguyen, Elizabeth Osterlund, Justin Kale

|Apr 20, 2023
The carboxyl-terminal sequence of PUMA binds to both anti-apoptotic proteins and membranes.

James M Pemberton, Dang Nguyen, Elizabeth J Osterlund

|Oct 25, 2022
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins.

Jenna E van Leeuwen, Wail Ba-Alawi, Emily Branchard

|Apr 20, 2022
Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells.

Elizabeth J Osterlund, Nehad Hirmiz, James M Pemberton

Pageof 5